$DOMH
Dominari Holdings Inc. Stock $domh

$domh Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023065013 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$963.0K	$71.00K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.070M	$9.080M
YoY Change	-9.86%	301.41%
% of Gross Profit
Research & Development		$2.000K
YoY Change		-94.44%
% of Gross Profit
Depreciation & Amortization	$30.00K	$20.00K
YoY Change
% of Gross Profit
Operating Expenses	$4.067M	$9.082M
YoY Change	-20.27%	295.21%
Operating Profit	-$3.104M	-$9.011M
YoY Change	-39.15%	292.12%
Interest Expense	-$440.0K	$560.0K
YoY Change	-61.34%	-120.15%
% of Operating Profit
Other Income/Expense, Net	-$437.0K	$348.0K
YoY Change	-61.6%	-112.52%
Pretax Income	-$3.540M	-$8.660M
YoY Change	-43.26%	70.57%
Income Tax
% Of Pretax Income
Net Earnings	-$3.541M	-$8.663M
YoY Change	-43.24%	70.63%
Net Earnings / Revenue	-367.71%	-12201.41%
Basic Earnings Per Share	-$0.66	-$1.79
Diluted Earnings Per Share	-$0.66	-$1.79
COMMON SHARES
Basic Shares Outstanding	5.345M shares	4.593M shares
Diluted Shares Outstanding	5.345M shares	4.827M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.66M	$24.27M
YoY Change	-41.62%	-40.18%
Cash & Equivalents	$4.388M	$3.598M
Short-Term Investments	$16.27M	$20.68M
Other Short-Term Assets	$7.900M	$7.800M
YoY Change	1039.97%	3879.59%
Inventory
Prepaid Expenses
Receivables	$6.300M	$6.300M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$34.89M	$38.42M
YoY Change	-37.81%	-37.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$361.0K	$387.0K
YoY Change	-49.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$22.70M	$23.20M
YoY Change	-12.99%	-8.94%
Other Assets	$500.0K	$500.0K
YoY Change	9.17%	222.58%
Total Long-Term Assets	$28.32M	$29.27M
YoY Change	-0.12%	9.5%
TOTAL ASSETS
Total Short-Term Assets	$34.89M	$38.42M
Total Long-Term Assets	$28.32M	$29.27M
Total Assets	$63.21M	$67.70M
YoY Change	-25.15%	-23.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$300.0K	$200.0K
YoY Change	-42.08%	40.85%
Accrued Expenses	$1.200M	$1.000M
YoY Change	-13.11%	45.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.722M	$2.658M
YoY Change	-9.32%	220.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.100M	$3.300M
YoY Change	342.23%
Total Long-Term Liabilities	$3.100M	$3.300M
YoY Change	342.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.722M	$2.658M
Total Long-Term Liabilities	$3.100M	$3.300M
Total Liabilities	$4.859M	$5.917M
YoY Change	86.88%	613.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$201.8M	-$198.3M
YoY Change	13.0%	15.04%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$501.0K	$501.0K
YoY Change	-79.97%	-71.37%
Treasury Stock Shares
Shareholders Equity	$58.35M	$61.78M
YoY Change
Total Liabilities & Shareholders Equity	$63.21M	$67.70M
YoY Change	-25.15%	-23.33%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$3.541M	-$8.663M
YoY Change	-43.24%	70.63%
Depreciation, Depletion And Amortization	$30.00K	$20.00K
YoY Change
Cash From Operating Activities	-$3.580M	-$9.920M
YoY Change	25.04%	387.23%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$60.00K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$4.370M	$4.040M
YoY Change	-2901.28%	-177.69%
Cash From Investing Activities	$4.360M	$3.990M
YoY Change	-740.23%	-176.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change	-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-3.580M	-9.920M
Cash From Investing Activities	4.360M	3.990M
Cash From Financing Activities	0.000	0.000
Net Change In Cash	780.0K	-5.930M
YoY Change	-118.16%	-81.38%
FREE CASH FLOW
Cash From Operating Activities	-$3.580M	-$9.920M
Capital Expenditures	$0.00	$60.00K
Free Cash Flow	-$3.580M	-$9.980M
YoY Change	53.12%	390.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-05576
	dei	Entity Registrant Name EntityRegistrantName	DOMINARI HOLDINGS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0849320
	dei	Entity Address Address Line1 EntityAddressAddressLine1	725 5th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	22nd Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(703)
	dei	Local Phone Number LocalPhoneNumber	992-9325
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
	dei	Trading Symbol TradingSymbol	DOMH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5345312	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3598000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33174000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	20675000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7130000	usd
CY2023Q2	domh	Clearing Broker Deposits ClearingBrokerDeposits	7082000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	715000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	564000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	301000	usd
CY2023Q2	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	6339000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7474000	usd
CY2022Q4	domh	Investment In Field Point Securitie InvestmentInFieldPointSecuritie	2000000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	38422000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50656000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	387000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1622000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1100000	usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	98000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	23178000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3530000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	919000	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2023Q2	us-gaap	Assets Assets	67695000	usd
CY2022Q4	us-gaap	Assets Assets	76236000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	232000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	447000	usd
CY2023Q2	domh	Accrued Salaries And Benefit AccruedSalariesAndBenefit	632000	usd
CY2022Q4	domh	Accrued Salaries And Benefit AccruedSalariesAndBenefit	1260000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1300000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	353000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	82000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	124000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2658000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1789000	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3259000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	680000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	5917000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2469000	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5345312	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5485096	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5285164	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5017079	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	260585000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262970000	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	60148	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	468017	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	501000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3322000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198306000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185881000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	61778000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67695000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76236000	usd
CY2023Q2	us-gaap	Revenues Revenues	71000	usd
	us-gaap	Revenues Revenues	71000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9080000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2262000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12913000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4049000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2052000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	9082000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2298000	usd
	us-gaap	Operating Expenses OperatingExpenses	12916000	usd
	us-gaap	Operating Expenses OperatingExpenses	6101000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9011000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2298000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12845000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6101000	usd
	us-gaap	Other Income OtherIncome	64000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	160000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	220000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	297000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	399000	usd
CY2023Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	400000	usd
CY2022Q2	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-2239000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	335000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-2736000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-212000	usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-212000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	760000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	238000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	348000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2779000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	420000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2511000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-8663000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5077000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12425000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8612000	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1100000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4109000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8663000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6177000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12425000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12721000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.79
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.42
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4827239	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5251023	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5065055	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5251766	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	69071000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1370000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-8663000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	61778000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	95051000	usd
CY2022Q2	domh	Deemed Dividends Related To Series O And Series P Redeemable Convertible Preferred Stock DeemedDividendsRelatedToSeriesOAndSeriesPRedeemableConvertiblePreferredStock	-1100000	usd
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1486000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	105000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	-26000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5077000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	87467000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1375000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	939000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-12425000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	61778000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101595000	usd
	domh	Deemed Dividends Related To Series O And Series P Redeemable Convertible Preferred Stock DeemedDividendsRelatedToSeriesOAndSeriesPRedeemableConvertiblePreferredStock	-4109000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1486000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	105000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	-26000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8612000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	87467000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12425000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8612000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	182000	usd
	us-gaap	Depreciation Depreciation	32000	usd
	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	1646000	usd
	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	-1408000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2675000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	105000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-487000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-568000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	514000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2299000	usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-212000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	229000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-153000	usd
	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost	-301000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-3532000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-428000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-239000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-628000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	7000	usd
	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions	-8000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	58000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	99000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	377000	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-8000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13913000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5850000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	34014000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	27460000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	20494000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	28272000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	93000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	419000	usd
	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet	1112000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	502000	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	100000	usd
	domh	Purchaseofshort Termandlong Terminvestments Purchaseofshort-termandlong-terminvestments	75000	usd
	domh	Purchaseofshort Termandlong Terminvestments Purchaseofshort-termandlong-terminvestments	14605000	usd
	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes	1600000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14724000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15300000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	17891000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	26000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-22000000	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	939000	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	1486000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-939000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5621000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29576000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26771000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33174000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65562000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3598000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38791000	usd
	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites	1482000	usd
	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue	2147000	usd
	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares	1508000	usd
	us-gaap	Stock Issued1 StockIssued1	3112000	usd
	domh	Less Deposit Previously Transferred In October2022 To Fps LessDepositPreviouslyTransferredInOctober2022ToFPS	2000000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1112000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</p>
CY2023Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	7100000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3400000	usd
	domh	Net Loss NetLoss	7700000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	70000.00	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	5400000	usd
CY2023Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	900000	usd
CY2023Q2	domh	Realizedloss Gain RealizedlossGain	432000	usd
CY2022Q2	domh	Realizedloss Gain RealizedlossGain	344000	usd
	domh	Realizedloss Gain RealizedlossGain	487000	usd
	domh	Realizedloss Gain RealizedlossGain	568000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	643000	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1967000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	514000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2299000	usd
CY2023Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	188000	usd
CY2022Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	72000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	308000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	131000	usd
CY2023Q2	domh	Marketable Securities Gain Losses MarketableSecuritiesGainLosses	400000	usd
CY2022Q2	domh	Marketable Securities Gain Losses MarketableSecuritiesGainLosses	-2239000	usd
	domh	Marketable Securities Gain Losses MarketableSecuritiesGainLosses	335000	usd
	domh	Marketable Securities Gain Losses MarketableSecuritiesGainLosses	-2736000	usd
CY2023Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	20922000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	23178000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2021Q4	domh	Purchase Shares PurchaseShares	250000	shares
CY2021Q4	domh	Payment Of Purchase Prices PaymentOfPurchasePrices	1000000	usd
CY2023Q1	domh	Purchase Shares PurchaseShares	64377	shares
CY2023Q2	domh	Additional Purchased Shares AdditionalPurchasedShares	150000	shares
CY2023Q2	domh	Payment Of Purchase Prices PaymentOfPurchasePrices	80000.00	usd
CY2023Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1080000.00	usd
CY2023Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1800000	usd
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	250000	usd
	us-gaap	Interest Income Other InterestIncomeOther	100000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	20675000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	20675000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	13000	usd
CY2023Q2	domh	Notes Receivable At Fair Value Current Portion NotesReceivableAtFairValueCurrentPortion	6339000	usd
CY2023Q2	domh	Notes Receivable At Fair Value Noncurrent Portion NotesReceivableAtFairValueNoncurrentPortion	1622000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7130000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	7130000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	13000	usd
CY2022Q4	domh	Notes Receivable At Fair Value Current Portion NotesReceivableAtFairValueCurrentPortion	7474000	usd
CY2022Q4	domh	Notes Receivable At Fair Value Noncurrent Portion NotesReceivableAtFairValueNoncurrentPortion	1100000	usd
	us-gaap	Lessee Finance Lease Description LesseeFinanceLeaseDescription	The initial term of the Company’s Lease is seven (7) years commencing on July 11, 2022 (“Commencement Date).
CY2023Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	12874	usd
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	13502	usd
CY2022Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	49368	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	51868	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
	us-gaap	Lease Cost LeaseCost	400000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	179	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	313	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	179	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	313	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	33	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	63	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	212	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	376	usd
CY2023Q1	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	644499	usd
CY2023Q1	domh	Shares Cancelled SharesCancelled	25000	shares
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	72000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2796000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	327000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	750000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	688000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	688000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	688000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	770000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1166000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5077000	usd
CY2023Q2	domh	Less Present Value Discount LessPresentValueDiscount	-1465000	usd
CY2023Q2	domh	Operating Lease Liabilities OperatingLeaseLiabilities	3612000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	475166	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	643404	shares
CY2023Q1	domh	Shares Cancelled SharesCancelled	644499	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2700000	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	503876	usd
CY2023Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	1300000	usd
CY2022Q1	domh	Share Buyback Program Amount ShareBuybackProgramAmount	3000000	usd
	domh	Share Repurchased ShareRepurchased	236630	shares
	domh	Amount Of Cost AmountOfCost	0.9	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.97
CY2023Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	644499	shares
CY2023Q1	domh	Original Cost OriginalCost	3800000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8068	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	529715	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.58
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	537783	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.63
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31193	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.97
CY2022Q4	domh	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual	P7Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	857	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9719.07
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30336	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.97
CY2023Q2	domh	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual	P7Y7M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	26578	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	41.35
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y6M
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	7000	usd
CY2023Q2	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	43000	usd
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	43000	usd
CY2023Q2	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	14000	usd
	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	14000	usd
CY2023Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther	14000	usd
	us-gaap	Noninterest Income Other NoninterestIncomeOther	14000	usd
CY2023Q2	us-gaap	Revenues Revenues	71000	usd
	us-gaap	Revenues Revenues	71000	usd
CY2023Q2	us-gaap	Excess Capital ExcessCapital	7200000	usd
CY2023Q2	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	100000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	80000.00	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	600000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
	us-gaap	Revenues Revenues		usd
CY2023Q2	us-gaap	Other Income OtherIncome		usd
CY2022Q2	us-gaap	Other Income OtherIncome		usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.18
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.79
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4827239	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5065055	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q2	domh	Redemption Of Series P Redeemable Convertible Preferred Stock RedemptionOfSeriesPRedeemableConvertiblePreferredStock		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Treasury Stock Retired Par Value Method Amount TreasuryStockRetiredParValueMethodAmount		usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	domh	Redemption Of Series P Redeemable Convertible Preferred Stock RedemptionOfSeriesPRedeemableConvertiblePreferredStock		usd
	domh	Cancellation Of Common Stock Related To Investment In Cb Min Shares CancellationOfCommonStockRelatedToInvestmentInCBMinShares		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Depreciation Depreciation		usd
	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment		usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost		usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet		usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes		usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites		usd
	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue		usd
	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022Q2	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss		usd
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss		usd
CY2022Q2	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue		usd
	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue		usd
CY2022Q2	us-gaap	Noninterest Income Other NoninterestIncomeOther		usd
	us-gaap	Noninterest Income Other NoninterestIncomeOther		usd
CY2022Q2	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000012239

Files In Submission

Name	View Source	Status
0001213900-23-065013-index-headers.html	Edgar Link	pending
0001213900-23-065013-index.html	Edgar Link	pending
0001213900-23-065013.txt	Edgar Link	pending
0001213900-23-065013-xbrl.zip	Edgar Link	pending
domh-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_dominari.htm	Edgar Link	pending
f10q0623ex31-2_dominari.htm	Edgar Link	pending
f10q0623ex32-1_dominari.htm	Edgar Link	pending
f10q0623ex32-2_dominari.htm	Edgar Link	pending
f10q0623_dominarihold.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
domh-20230630_def.xml	Edgar Link	unprocessable
domh-20230630_lab.xml	Edgar Link	unprocessable
domh-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_dominarihold_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
domh-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOMH
Dominari Holdings Inc. Stock $domh

2023 Q3 Form 10-Q Financial Statement

#000121390023065013 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH Dominari Holdings Inc. Stock $domh

2023 Q3 Form 10-Q Financial Statement

#000121390023065013 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH
Dominari Holdings Inc. Stock $domh